SRC and ovarian serous adenocarcinoma: The most common subtype, high-grade serous ovarian cancer (HGSOC), has been shown to display the frequent activation of Src, which has been associated with later stages of the disease, chemotherapeutic resistance, and, ultimately, decreased survival [35].